Biocan DHPPi+LR, Lyofilizát a rozpouštědlo pro injekční suspenzi
Biocan DHPPi+LR, Lyofilizát a rozpouštědlo pro injekční suspenzi
Authorised
- Canine distemper virus, Live
- Canine adenovirus 2, Live
- Canine parvovirus, Live
- Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain MSLB 1008, Inactivated
- Leptospira interrogans, serogroup Canicola, serovar Canicola, strain MSLB 1010, Inactivated
- Canine parainfluenza virus, Live
- Leptospira kirschneri, serogroup Grippotyphosa, serovar Grippotyphosa, strain MSLB 1009, Inactivated
- Rabies virus, strain SAD Vnukovo-32, Inactivated
Product identification
Medicine name:
Biocan DHPPi+LR, Lyofilizát a rozpouštědlo pro injekční suspenzi
Active substance:
- Canine distemper virus, Live
- Canine adenovirus 2, Live
- Canine parvovirus, Live
- Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain MSLB 1008, Inactivated
- Leptospira interrogans, serogroup Canicola, serovar Canicola, strain MSLB 1010, Inactivated
- Canine parainfluenza virus, Live
- Leptospira kirschneri, serogroup Grippotyphosa, serovar Grippotyphosa, strain MSLB 1009, Inactivated
- Rabies virus, strain SAD Vnukovo-32, Inactivated
Target species:
-
Dog
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Canine distemper virus, Live4.50/log10 50% tissue culture infectious dose1.00Dose
-
Canine adenovirus 2, Live4.50/log10 50% tissue culture infectious dose1.00Dose
-
Canine parvovirus, Live5.50/log10 50% tissue culture infectious dose1.00Dose
-
Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain MSLB 1008, Inactivated32.00/Antibody microagglutination-lytic reaction1.00Dose
-
Leptospira interrogans, serogroup Canicola, serovar Canicola, strain MSLB 1010, Inactivated32.00/Antibody microagglutination-lytic reaction1.00Dose
-
Canine parainfluenza virus, Live4.20/log10 50% tissue culture infectious dose1.00Dose
-
Leptospira kirschneri, serogroup Grippotyphosa, serovar Grippotyphosa, strain MSLB 1009, Inactivated32.00/Antibody microagglutination-lytic reaction1.00Dose
-
Rabies virus, strain SAD Vnukovo-32, Inactivated2.00/international unit(s)1.00Dose
Pharmaceutical form:
-
Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
-
Dog
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07AJ06
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Czechia
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
- Bioveta a.s.
Responsible authority:
- Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
- 97/016/04-C
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Czech (PDF)
Published on: 26/10/2022
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Czech (PDF)
Published on: 26/10/2022
Labelling
This document does not exist in this language (English). You can find it
in another language below.
Czech (PDF)
Published on: 26/10/2022
How useful was this page?:
